Smart report aims to match breast cancer drugs to tumor biology
NCT ID NCT07590583
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether a biology-guided therapy recommendations report can help doctors choose treatments for advanced hormone receptor-positive breast cancer that cannot be removed by surgery or has spread. Researchers will analyze tumor tissue from 20 patients to create a report suggesting which drugs might work best and which the cancer may resist. The main goal is to see if the report can be delivered quickly enough to be useful in real-world care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- biology-guided therapy recommendations report
- What this could lead to
- If successful, this could show that personalized treatment reports based on tumor biology are practical and helpful for guiding therapy in advanced breast cancer.
- What could go wrong
- This is a very small, early pilot study (20 people) focused on feasibility, not on proving the treatment works. The report may not improve outcomes or may be too slow to be useful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Gut bacteria may fortify bones in breast cancer therapy
- Digital therapy aims to tame the fear that haunts cancer survivors
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
- Engineered immune cells join chemo and antibody to attack Hard-to-Treat breast cancer
- Can a vaccine train the immune system to hunt down hidden breast cancer cells?